|
|
||||||||
1 Dipartimento di Medicina Sperimentale, Sezione di Patologia Molecolare e Immunologia, Università degli Studi di Parma, 43100 Parma; 2 Centro Substrati Cellulari, Istituto Zooprofilattico Sperimentale, 25125 Brescia, Italy; and 3 School of Biological Sciences, University of Sussex, Brighton BN1 9QG, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
We studied the responses to hypertonicity of cultured endothelial cells from swine pulmonary arteries. In 0.5 osmol/kgH2O medium, initial cell shrinkage was followed by a regulatory volume increase (RVI), complete after 1 h, concomitant with an increase in cellular K+ content. Then the activity of amino acid transport System A increased, accompanied by an accumulation of ninhydrin-positive solutes (NPS), reaching a peak at ~6 h. The subsequent decline in System A activity was paralleled by an induction of the betaine-GABA transporter (BGT-1), detected as increases of BGT-1 mRNA and of transport activity, which peaked at ~24 h. Inhibitors of transcription or translation prevented induction of both transport activities. The increased expression of BGT-1, which involved activation of "tonicity-responsive enhancer," was inhibited by 5 mM extracellular betaine. Cellular K+ concentration gradually declined after the accumulation of NPS and during the induction of BGT-1. This very effective adaptation to hypertonicity suggests it has a physiological role.
membrane transport; osmolyte; regulatory volume increase; volume
| |
INTRODUCTION |
|---|
|
|
|---|
EXPOSURE OF ANIMAL CELLS to hypertonicity induces an immediate cell shrinkage by osmosis usually followed by an early regulatory volume increase (RVI) mediated by the uptake of inorganic ions and accompanying water (19). Thus the consequence of this response to the extracellular pressure is an abnormally high concentration of inorganic ions inside the cells. This early phase of RVI is followed in some cells by the substitution of various "compatible osmolytes" in place of some of the inorganic ions, which enables the cells to maintain a cell volume adequate for their survival in the adverse hypertonic environment (5). The usual explanation of this is the need to overcome the deleterious effects of high salt concentrations on macromolecular structures that otherwise would eventually impair or destroy normal cell function. Osmotically equivalent concentrations of "compatible osmolytes," such as methylamines, polyols, and some amino acids or amino acid derivatives, do not perturb protein or nucleic acid structures (53). This process of cell adaptation to hypertonicity often involves changes in gene expression that result in an increase in either the synthesis or the accumulation of compatible osmolytes (6, 28).
In a number of cultured cells, exposure to hypertonic medium produces an early (2-6 h) increased activity of amino acid transport System A (8, 12, 14, 15, 25, 41, 42, 46, 49). After more prolonged (8-24 h) exposure of cells to hypertonicity, an increased activity of the betaine-GABA (BGT-1) transporter has been described in kidney-derived epithelial cells (17, 24, 41, 52) and in vascular endothelial cells obtained from calf pulmonary artery (25). Primary cultures of porcine chondrocytes respond in an exactly parallel fashion, although the induced betaine-GABA transporter in these cells may not be BGT-1 (15). On the other hand, rat liver sinusoidal endothelial cells (51), such as RAW 264.7 mouse macrophages (50), human monocytes, and macrophages (16), respond to hypertonic conditions with an early (6-12 h) upregulation of the BGT-1 transporter.
Although these responses of kidney-derived epithelial cells, and perhaps of chondrocytes, to hypertonicity are readily understandable in terms of their normal physiological functions, the similar behavior of the other cells is not so obviously explicable. Endothelial cells mediate and monitor the exchange of molecules between the plasma and the interstitial fluid, participating in homeostasis and playing a critical role in the inflammatory process (22). Because they are normally exposed to isotonic fluids containing rather constant nutrient supplies, however, it is not obvious why they should possess mechanisms that enable them to cope with hypertonicity. It is possible that certain pathological or trauma conditions might require such responses (1); under diabetic conditions, for example, endothelial cells are exposed to hyperglycemia, but normally isotonic volume changes are more likely (36). Despite this uncertainty, the somewhat different responses reported for two different kinds of endothelial cells, one similar to the kidney-derived cells and the other to monocytes and macrophages, are both impressively efficacious in coping with hypertonicity. The existence of these responses, which are quite costly in terms of metabolic input, suggest they have a physiological role.
Endothelial cells are a very heterogeneous class, with functional differences between those derived from arterial or venous origin, large or small vessels, and various different microvascular beds. There are also differences between endothelia from different species (2). More detailed study of their properties and behavior has been facilitated by recent improvements in culture techniques that provide endothelial cells from different origins able to maintain in vitro the differentiated properties of the original endothelium. We have examined in some detail the adaptive responses to a hypertonic environment of cultured endothelial cells derived from pig pulmonary arteries. The present work describes the adaptation from the initial cell shrinkage followed by changes in inorganic ion concentrations, the occurrence of an RVI, the induction of both System A and BGT-1 transport activities, the accumulation of their specific substrates, and the regulation of BGT-1 gene expression by accumulated betaine.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Chemicals.
-[32P]dCTP,
-[32P]ATP,
3-O-methyl-D-[1-3H]glucose,
L-[4,5-3H]leucine, and
-amino[2,3-3H]butyric acid were obtained from Amersham
International, Amersham, Bucks, UK.
2-[1-14C]methylaminoisobutyric acid (MeAIB) was obtained
from DuPont-New England Nuclear (Boston, MA). Choline oxidase, betaine,
GABA, methylaminoisobutyric acid, collagenase type IA
were bought from Sigma Chemical, Poole, Dorset, UK.
[14C]betaine was prepared from [14C]choline
by enzymic oxidation (41). A plasmid containing
full-length BGT-1 cDNA (52) was kindly provided by Dr. Moo
Kwon, Division of Nephrology, The Johns Hopkins University School of
Medicine, Baltimore, MD, and a probe for 28S rRNA was obtained from Dr. Lorenza Tacchini (University of Milan, Italy). Single-stranded oligonucleotides containing the hypertonicity-responsive element Ton-E
(upper stranded 5'-TACTTGGTGGAAAAGTCCAG-3')
were obtained from Primm (Milan, Italy). Media, fetal calf serum, and
antibiotics for culturing the cells were purchased from GIBCO (Grand
Island, NY). Disposable plastics for laboratory use were obtained from
Costar (Broadway, Cambridge, MA). Reagents of analytic grade were
purchased from Sigma Chemical.
Cell culture. Pulmonary arteries were obtained aseptically from healthy 3-wk-old pigs after they had been given an anesthetic. The vessels were submersed in 100 ml of Medium 199 containing penicillin (1,000 U/ml), streptomycin (500 µg/ml), and amphotericin B (2 µg/ml) (29). The fat and connective tissue surrounding blood vessels were removed, and the remaining tissue was minced with scissors. Pieces of tissue were then incubated for 2 h at 37°C in Medium 199 containing, in addition to the antibiotics listed above, 0.25% collagenase (type 1A) and 0.25% bovine serum albumin. The resultant cell suspension was rinsed in Medium 199 containing fetal calf serum (10% vol/vol) and filtered through a 20 µm pore size filter to remove all microaggregates containing unwanted cells. After centrifugation of the filtrate at 1,000 g for 20 min, the resulting pellets were resuspended in endothelial basal Medium 199 supplemented with fetal calf serum (10%), heparin (50 U/ml), hydrocortisone (1 µg/ml), epidermal growth factor (10 µg/ml), and endothelial cell growth supplement (50 µg/ml). The cells were seeded in 75-cm2 flasks coated with sterile gelatin (2%). After cell attachment was ascertained by examining the flasks with an inverted microscope, the medium was removed and fresh medium was added to cell culture. Subsequently, the medium was changed again at 2-day intervals. The first confluence was obtained after ~10 days. Subpassages were made weekly by rinsing confluent monolayers with PBS and dispersing the sheet with a trypsin-EDTA solution. The cell suspension was inoculated into new flasks coated with 2% gelatin, and cells were used when confluent, usually within 3-5 days after plating. Growth medium was Dulbecco's modified Eagle's medium containing 100 U/ml penicillin, 100 µg/ml streptomycin, and supplemented with 2 mM glutamine, 2 mM sodium pyruvate, 20 mM HEPES (pH 7.4), 10% fetal calf serum, 50 U/ml heparin, and 50 µg/ml endothelial cell growth supplement. All cultures were kept in an incubator at 37°C in a water-saturated atmosphere of 5% CO2 in air. Cells used in this study were all of early (up to the 10th) passages and were routinely checked for the expression of von Willebrand Factor by immunocytochemistry. Rabbit anti-human von Willebrand Factor (DAKO) was the purified immunoglobulin fraction of rabbit antiserum and cross-reacted with von Willebrand Factor from pig.
Culture media. The osmolalities of the culture media were checked with a vapor-pressure osmometer (Wescor). Normal growth medium was ~0.3 osmol/kgH2O. Except where indicated (see Fig. 6A), hypertonic growth medium was made by addition of 200 mM sucrose to normal growth medium, giving a final osmolality of ~0.5 osmol/kgH2O.
Cell counting and determination of cell survival. Cells were detached from the substratum with trypsin, and appropriate dilutions of the resulting suspension were counted in a hemocytometer, as described in detail previously (44). Cell survival was determined by cell viability and colony formation. After hyperosmotic treatment, the cells were removed from the plates with trypsin and counted, and their viability was determined by trypan blue exclusion (20). Colony formation by viable cells was then determined by seeding them at a density of 400 cells/9 cm2 in dishes containing 2 ml of culture medium. After 5-6 days incubation, the cells were fixed with 95% ethanol, stained with 0.1% crystal violet, and counted.
Determination of the rate of protein synthesis. The rate of protein synthesis was measured as the rate of incorporation of labeled leucine of constant specific activity (2.5 mCi/mmol, 2 µCi/ml) during a 30-min incubation of the cell monolayers in complete culture medium containing 0.8 mM leucine. This procedure has been described in detail elsewhere (43).
Determination of cell volume. Intracellular volumes were estimated by measurement of the equilibrium distribution of 3-O-methyl-D-[1-3H]glucose as described previously (49) using the method of Kletzien et al. (27).
Assay of Na+ and K+ content. The amounts of intracellular Na+ and K+ were estimated by the following procedure, based on that described by Dall'Asta et al. (13). Cell layers were quickly washed four times with ice-cold 0.1 M MgCl2 and drained for a few minutes by inversion of the plates. The cells were then denatured by the addition of ethanol (0.5 ml/well) and allowed to dry before the cations were extracted with 10 mM CsCl (2 ml/well). The concentrations of Na+ and K+ ions in these extracts were measured with a Varian AA-275 atomic absorption spectrophotometer and standard solutions of NaCl and KCl containing 10 mM CsCl. The extracted cells were dissolved in 0.2 M NaOH, and samples were used for the assay of protein content as described below.
Ninhydrin-positive substances. The intracellular content of ninhydrin-positive substances (NPS) was measured by the method of Law and Turner (31) and expressed as nanomoles per milligram of protein.
Transport measurements.
The rates of uptake of amino acids or betaine by endothelial cells were
measured after the latter had been incubated in isotonic (0.3 osmol/kgH2O) or hypertonic (0.5 osmol/kgH2O)
medium for the desired time. MeAIB was used as the characterizing
substrate of amino acid transport System A in many types of mammalian
cells (11, 18), including human endothelial cells derived
from the umbilical vein (7). The cell monolayers were
quickly washed with Earle's balanced salt solution containing 0.1%
glucose and then incubated in this solution for 15 min at 37°C to
diminish the cellular pool of amino acids. The cells were washed again and immediately incubated at 37°C for the desired time in the presence of labeled betaine, GABA, or MeAIB. When required, choline was
then used in place of Na+ in the medium and acetate in
place of Cl
. The incubations were stopped by removal of
the medium, and the cells were quickly washed three times with fresh
cold medium. Trichloroacetic acid (5%, wt/vol) was added to denature
the cells, and the radioactivity in samples of the acid extracts was
measured by scintillation counting. Cell protein, precipitated by TCA, was dissolved in 0.2 N NaOH and its concentration was determined by a
dye-fixation method (BioRad) using bovine serum albumin as standard
(4).
Northern blotting.
Total RNA was extracted from cultured cells using the Ultraspec RNA
Isolation System from Biotecx (10). RNA samples (20 µg)
were fractionated by electrophoresis through 1% agarose gels, and the
separated bands were transferred to nylon filters. The quality and
quantity of RNA blotted on the membranes were checked by ultraviolet
absorption. Full-length BGT-1 cDNA (52) and 28S rRNA were
nick-translated (Amersham kit no. 5000) with
[
-32P]dCTP (3,000 Ci/mmol). Hybridization, washing,
and autoradiography were carried out exactly as described previously
(40).
Gel mobility-shift analysis.
The gel retardation assay was conducted essentially as described by
Mosser et al. (33) and Choi et al. (9) with
the use of a double-stranded synthetic consensus oligonucleotide
corresponding to nucleotides
69/
50 in the 5'-flanking
region of the canine BGT-1 gene containing the hypertonicity-responsive element Ton-E (48). The entire procedure has been
described in detail previously (39).
Statistical analyses. Results are expressed as mean values ± SE for the indicated number of independent measurements. The significance of differences between the mean values recorded for different experimental conditions was calculated by the Student's t-test, and P values are indicated where appropriate in the figures and their legends.
| |
RESULTS |
|---|
|
|
|---|
Effects of hypertonicity on cell protein synthesis, growth, and
survival.
Hypertonic treatment did not affect the ability of endothelial cells to
form colonies but did cause a decrease (~50%) in the rate of cell
growth during the first 24 h of incubation in 0.5 osmol/kgH2O medium. Subsequently, however, the rate of cell
proliferation increased, whereas that of cells in isotonic medium
slowed, so that after another 24 h cell density under hypertonic
conditions was only a little lower than under isotonic conditions (Fig.
1A). Total protein synthesis
was inhibited >40% during the first 30 min of exposure of the cells
to hypertonic medium. Thereafter recovery was rapid, so that after
2 h the inhibition was <20% and by 4 h there was no
significant difference between cells from hypertonic and isotonic
conditions (Fig. 1B). Taken together, these data show that
endothelial cells survive the hypertonic challenge and, after a
transient period of inhibition, resume their usual growth rate in this
adverse environment.
|
Cell volume, cation, and NPS content.
The volume of the endothelial cells was monitored during their
incubation in 0.5 osmol/kgH2O medium. To determine cell
volume changes at early times of the hypertonic treatment, we measured the concentration of labeled methylglucose in cells that had been preincubated with the tracer before treatment until it had reached equilibrium distribution. With the use of these conditions, cell shrinkage was observed during the first few minutes of incubation at
0.5 osmol/kgH2O. This rapid shrinkage was followed by an
RVI, and the cells regained the volume of control cells within 1 h of treatment (Fig. 2).
|
|
|
Induction of transport activities.
Continuous incubation of endothelial cells in 0.5 osmol/kgH2O medium resulted in a marked but temporary
increase in the ability of the cells to take up MeAIB, taken as a
measure of the activity of amino acid transport System A. The increased
uptake of MeAIB (measured as initial rate of transport) was detected as
early as 3 h after the beginning of the treatment, reached a
maximum after 6 h, and then slowly declined toward isotonic
control values (Fig. 5). This hypertonic
treatment also resulted in a progressive increase in the transport
activity of BGT-1, assayed by the measurement of the initial rates of
uptake of GABA. The timing of this increase, however, was quite
different, being just detectable at 6 h it then followed a sigmoid
activation curve to reach a maximum at ~24 h (Fig. 5). These
inductions of transport activity appear to depend only on the change in
osmolarity of the culture medium, rather than on any specific solute or
ionic effect, because similar responses were observed when extra NaCl
was used instead of extra sucrose to make the culture medium hypertonic
(Fig. 6A).
|
|
|
Characteristics of induced GABA transport.
The dependence of GABA transport on inorganic ions was checked for the
characteristics expected of BGT-1 activity. Figure 8A shows clearly that the
induced GABA transport activity was not only Na+ dependent
but also anion dependent, acetate supporting only ~25% of the uptake
given with Cl
as the main anion. Much of the smaller
influx of GABA into the isotonic control cells was similarly dependent
on Na+ and Cl
. Similar results were obtained
when gluconate was used to replace chloride. Mean values (±SE,
n = 6) for GABA uptake (nmol · mg protein
1 · 5 min
1) from media
containing mainly NaCl, sodium acetate, or sodium gluconate,
respectively, were 1.10 ± 0.03, 0.53 ± 0.01, and 0.53 ± 0.01 under isotonic conditions and 7.88 ± 0.26, 2.02 ± 0.08, and 2.25 ± 0.005 under hypertonic conditions. Figure
8B shows that the rate of betaine uptake similarly increased
after incubation of the cells for 24 h in hypertonic medium. In
addition, betaine influx was almost completely inhibited by the
addition of 10 mM GABA, but not significantly affected by 10 mM MeAIB.
All these observations support the notion that GABA influx reflects
BGT-1 activity and indicate that betaine is taken up almost completely via system BGT-1 in cells exposed to hypertonic conditions for 24 h.
|
Betaine uptake during hypertonic incubation.
Endothelial cells incubated in media containing 0.1 mM betaine
accumulated this compatible osmolyte so that its intracellular concentration was higher than that outside under both isotonic and
hypertonic conditions (Fig. 9). The
extent of accumulation, however, was much greater under hypertonic
conditions, the cellular concentration reaching ~20-25 mM after
24 h.
|
Effects of actinomycin D and cycloheximide.
The requirement of transcription and translation for the hypertonic
induction of the transport activities was explored with the use of
specific inhibitors of both gene expression steps: actinomycin D (80 nM) and cycloheximide (35 µM), which inhibit RNA or protein
synthesis, respectively, by ~90% in cultured animal cells
(49). As shown in Fig. 10,
each inhibitor markedly decreased the induction of uptake of both MeAIB
and GABA, thus showing the requirement of gene expression for the
induction of both System A and BGT-1 activities. (The apparent
stimulatory effect of both inhibitors on the control value of GABA
uptake may be explained in terms of the lower cell density reached by
the endothelial cultures in the presence of actinomycin D or
cycloheximide during the 16 h incubation; see Fig. 7.)
|
Induced transcription of transporter mRNA.
The mRNA coding for the BGT-1 transporter has been isolated from
Madin-Darby canine kidney (MDCK) cells and the gene cloned (52). We tested the endothelial cells to see if the
induced GABA transport activity was accompanied by increased gene
expression detectable by a BGT-1 probe. Northern blotting with
full-length BGT-1 cDNA readily revealed the presence of BGT-1 mRNA in
both MDCK cells and the endothelial cells exposed to hypertonic (0.5 osmol/kgH2O) conditions for 20 h, but not in control
cells incubated in isotonic (0.3 osmol/kgH2O) conditions
(Fig. 11). This result suggests,
therefore, that the increase in transport of GABA and betaine observed
in endothelial cells cultured in hypertonic conditions is due to an
increased expression of a gene identical, or very similar, to the BGT-1
gene of the MDCK cells. It also indicates that no marked difference in
the sequence of this gene occurs in the cells of these different
tissues (kidney/endothelium) and species (canine/porcine).
|
1 · 5 min
1 by GABA]. In keeping with these
observations, the presence of 5 mM betaine similarly inhibited the
hyperosmotic induction of BGT-1 mRNA (Fig. 11).
|
1 · mg
protein
1). Transfer to 0.3 osmol/kgH2O medium
resulted in a faster decay, with a 50% reduction after 8 h (from
6.5 to 3.3 nmol GABA · 5 min
1 · mg
protein
1).
Induction of Ton-E binding.
Takenaka et al. (48) identified a regulatory element
(which they named Ton-E) in the promoter region of the BGT-1 gene in MDCK cells that mediates the transcriptional stimulation in response to
hypertonicity. We used the gel mobility-shift assay to see if the
increased expression of the BGT-1 gene in the endothelial cells is
related to activation of Ton-E. As shown in Fig.
13, extracts from the endothelial cells
that had been exposed to hypertonic (0.5 osmol/kgH2O)
conditions for 16 h mimicked those from similarly treated MDCK
cells in producing a band shift. Competition with an excess of
unlabeled Ton-E oligonucleotide indicated that the observed binding was
specific and extracts from control cells incubated under isotonic (0.3 osmol/kgH2O) conditions did not produce a band shift.
|
| |
DISCUSSION |
|---|
|
|
|---|
The most notable feature of these observations is the remarkable ability of the endothelial cells to adapt to hypertonic conditions: they appear to be as good, if not better, than MDCK cells in this respect. As has been pointed out by O'Neill (36), mammalian cells do need volume-regulatory mechanisms for a number of reasons and control of cell volume appears to be particularly important for the barrier function of endothelial cells (23). However, isotonic volume change, resulting from a change in the cellular content of osmotically active molecules, is much more likely than anisotonic change due to a change in extracellular osmolarity (36). There seems to be no evidence for an exposure of endothelial cells to hypertonicity parallel to that normally experienced by some kidney cells. Yet the response of these porcine endothelial cells to hypertonic stress is remarkably similar to that of MDCK cells, particularly with regard to the induction of System A and BGT-1 activities. In this respect they resemble endothelial cells from calf pulmonary artery (25) rather than rat liver sinusoidal endothelial cells (51). The latter, however, together with RAW 264.7 mouse macrophages (50), human monocytes, and macrophages (16), also adapt extremely well to hypertonicity and respond unusually quickly in terms of the induction of BGT-1 after only 6-12 h of exposure to hypertonic conditions. As far as we know, there are no reports about the induction of the amino acid transport System A in these latter cells. This would be interesting to test, because in the endothelial cells from pulmonary arteries, as in most other cells examined, it is the induction of System A that reaches a peak after ~6 h exposure to hypertonicity.
Regulatory volume increase.
These results show that K+ influx plays a major role in the
RVI after the initial hypertonic cell shrinkage. The early changes in
cell content and concentration of K+ are consistent with
influx of Na+ and K+ via
Na+-K+-Cl
cotransport being the
primary response to hypertonicity in these cells. The consequent
increase of cellular Na+ concentration would increase the
rate of Na+-K+-ATPase activity, expelling
Na+ in return for more K+, so that the net
result would be a gain of K+, as observed. This
interpretation is consistent with other reports of the involvement of
Na+-K+-Cl
cotransport in the
regulation of the volume of other endothelial cells (26, 34, 35,
37). With sucrose as the extra osmolyte, however, it is not sure
whether the net driving force for this cotransport is inward. From the
figures we have, the cellular Cl
concentration in the
shrunken cells would have to be less than ~35 mM to make
([Na+][K+][Cl
]2)out > ([Na+][K+][Cl
]2)in
and involvement of Na+-K+-Cl
cotransport likely. The other possibility is an increased
Na+ influx via the Na+/H+
exchanger, similarly coupled with increased sodium-pump activity (36). Further experiments, particularly with the use of
appropriate inhibitors, will be required to check these possibilities.
Induction of transport activities. The primary response to hypertonicity in endothelial cells derived from saphenous veins appears to be the induction of System A and the subsequent accumulation of amino acids, particularly glutamine and proline (12). Our results on the accumulation of NPS, which occurs in parallel with induction of System A activity, indicates that the accumulation of amino acids as compatible osmolytes is a secondary response, with maximum accumulation coinciding with the gradual loss of excess K+ (Figs. 3 and 4). Cell volume had already been restored at that stage, so that the increased intracellular accumulation of neutral amino acids presumably enables the excess salt content to be reduced, although the exact mechanism by which K+ leaves the cells is uncertain. The cellular concentration of NPS obtained, however, was only ~70 mM, insufficient to account for the extra external osmolarity of 0.2 osM, so some other solute must also have been accumulated. Hypertonic induction of BGT-1 occurred concomitantly with the downregulation of System A, and cells exposed to hypertonic medium containing 100 µM betaine did accumulate it, but only to 20-30 mM (Fig. 10). Hence, although any betaine present in the usual experimental media is likely to have been used as a compatible osmolyte, there would not have been enough to make up the osmotic imbalance noted above. The other likely contributions are from a similarly induced uptake of other compatible osmolytes, such as taurine or myo-inositol, or an induced synthesis of sorbitol (51).
Regulation. Regulatory sequences similar to Ton-E have been discovered in the promoter of the aldose reductase gene of several species (21) and it seems likely that other similar regulatory elements exist in connection with many cellular responses to increased osmolarity. There is some evidence that a regulatory protein is involved in the osmotic induction of System A activity (46); studies with inhibitors indicated that p38 MAP kinase is involved in the induction of BGT-1 in MDCK cells (47) as well as human monocytes and macrophages (16). Otherwise, little is known at present about the cellular mechanisms that specifically induce System A and BGT-1 activities in cells exposed to hypertonicity. The way in which added betaine (or GABA) inhibits the induction of the transport activity is also unclear, although it presumably involves specific binding of the betaine to some intracellular regulatory molecule.
Overall, these results support the view that a variety of mechanisms involved in the regulation of cell volume are not only widespread but also are likely to be physiologically significant (30, 36) even when the reason for their presence in a particular type of cell is not immediately obvious. From a practical viewpoint, the existence of these responses in endothelial cells must be important to the success of therapeutic treatments for hypovolemic shock (32).| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by a grant from Ministero della Universita e della Ricerca Scientifica e Tecnologica, Rome.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: K. P. Wheeler, School of Biological Science, Univ. of Sussex, Brighton BN1 9QG, UK (E-mail: k.p.wheeler{at}sussex.ac.uk).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 22 September 1999; accepted in final form 6 July 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akarasereenont, P,
Mitchell JA,
Bakhle YS,
and
Thermermann C.
Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages.
Eur J Pharmacol
273:
121-128,
1995[ISI][Medline].
2.
Bicknell, R.
Endothelial Cell Culture. Cambridge, UK: Cambridge University Press, 1996.
3.
Borghetti, AF,
Piedimonte G,
Tramacere M,
Severini A,
Ghiringhelli P,
and
Guidotti GG.
Cell density and amino acid transport in 3T3, SV3T3, and SV3T3 revertant cells.
J Cell Physiol
105:
39-49,
1980[ISI][Medline].
4.
Bradford, MM.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem
72:
248-254,
1976[ISI][Medline].
5.
Burg, MB.
Molecular basis of osmotic regulation.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F983-F996,
1995
6.
Burg, MB,
Kwon ED,
and
Kultz D.
Regulation of gene expression by hypertonicity.
Ann Rev Physiol
59:
437-455,
1997[ISI][Medline].
7.
Bussolati, O,
Sala R,
Astorri A,
Rotoli BM,
Dall'Asta V,
and
Gazzola GC.
Characterization of amino acid transport in human endothelial cells.
Am J Physiol Cell Physiol
265:
C1006-C1014,
1993
8.
Chen, JG,
Klus LR,
Steenbergen DK,
and
Kempson SA.
Hypertonic upregulation of amino acid transport system A in vascular smooth muscle cells.
Am J Physiol Cell Physiol
267:
C529-C536,
1994
9.
Choi, HS,
Lin Z,
Li B,
and
Liu AYC
Age-dependent decrease in the heat-inducible DNA sequence-specific binding activity in human diploid fibroblasts.
J Biol Chem
265:
18005-18011,
1990
10.
Chomczynski, P,
and
Sacchi N.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:
156-159,
1987[ISI][Medline].
11.
Christensen, HN.
Recognition sites for material transport and information transfer.
Curr Top Membr Transport
6:
227-258,
1975.
12.
Dall'Asta, V,
Bussolati O,
Sala R,
Parolari A,
Alamanni F,
Biglioli P,
and
Gazzola GC.
Amino acids are compatible osmolytes for volume recovery after hypertonic shrinkage in vascular endothelial cells.
Am J Physiol Cell Physiol
276:
C865-C872,
1999
13.
Dall'Asta, V,
Gazzola GC,
Longo N,
Bussolati O,
Franchi-Gazzola R,
and
Guidotti GG.
Perturbation of Na+ and K+ gradients in human fibroblasts incubated in unsupplemented saline solutions.
Biochim Biophys Acta
860:
1-8,
1986[Medline].
14.
Dall'Asta, V,
Rossi PA,
Bussolati O,
and
Gazzola GC.
Response of human fibroblasts to hypertonic stress.
J Biol Chem
269:
10485-10491,
1994
15.
De Angelis, E,
Petronini PG,
Borghetti P,
Borghetti AF,
and
Wheeler KP.
Induction of betaine-
-aminobutyric acid transport activity in porcine chondrocytes exposed to hypertonicity.
J Physiol (Lond)
518:
187-194,
1999
16.
Denkert, C,
Warskulat U,
Hensel F,
and
Haussinger D.
Osmolyte strategy in human monocytes and macrophages: involvement of p38MAPK in hyperosmotic induction of betaine and myoinositol transporters.
Arch Biochem Biophys
354:
172-180,
1998[ISI][Medline].
17.
Garcia-Perez, A,
and
Burg MB.
Renal medullary organic osmolytes.
Physiol Rev
71:
1081-1115,
1991
18.
Guidotti, GG,
Borghetti AF,
and
Gazzola GG.
The regulation of amino acid transport in animal cells.
Biochim Biophys Acta
515:
329-366,
1978[Medline].
19.
Hoffmann, EK,
and
Dunham PB.
Membrane mechanisms and intracellular signalling in cell volume regulation.
Int Rev Cytol
161:
173-262,
1995[ISI][Medline].
20.
Hunt, SV.
Preparation of lymphocytes and accessory cells.
In: Lymphocytes: A Practical Approach, edited by Klaus GGB. Oxford: IRL Press, 1987, p. 1-34.
21.
Iwata, T,
Minucci S,
McGovan M,
and
Carper D.
Identification of a novel cis-element required for a constitutive activity and osmotic response of a rat aldose reductase promoter.
J Biol Chem
272:
32500-32506,
1997
22.
Jaffe, EA.
Cell biology of endothelial cells.
Human Pathol
18:
234-239,
1987[ISI][Medline].
23.
Kajimura, M,
O'Donnell ME,
and
Curry FE.
Effect of cell shrinkage on permeability of cultured bovine aortic endothelia and frog mesenteric capillaries.
J Physiol (Lond)
503:
413-425,
1997[ISI].
24.
Kempson, SA.
Differential activation of system A and betaine/GABA transport in MDCK cell membranes by hypertonic stress.
Biochim Biophys Acta
1372:
117-123,
1998[Medline].
25.
Kempson, SA,
Hoshaw MJ,
Hinesley RS,
and
McAteer JA.
Hyperosmotic stress up-regulates amino acid transport in vascular endothelial cells.
Kidney Int
52:
1332-1339,
1997[ISI][Medline].
26.
Klein, JD,
Lamitina ST,
and
O'Neill WC.
JNK is a volume-sensitive kinase that phosphorylates the Na-K-2Cl cotransporter in vitro.
Am J Physiol Cell Physiol
277:
C425-C431,
1999
27.
Kletzien, RF,
Pariza MW,
Becker JE,
and
Potter VR.
A method using 3-O-methyl-D-glucose and phloretin for the determination of intracellular water space of cells in monolayer culture.
Anal Biochem
68:
537-544,
1975[ISI][Medline].
28.
Kwon, HM,
and
Handler JS.
Cell volume regulated transporters of compatible osmolytes.
Curr Opin Cell Biol
7:
465-471,
1995[ISI][Medline].
29.
Lamar, CH,
Turek JJ,
Bottoms GD,
and
Fessler JF.
Equine endothelial cells in vitro.
Am J Vet Res
47:
956-958,
1986[ISI][Medline].
30.
Lang, F,
Busch GL,
Ritter M,
Völkl H,
Waldegger S,
Gulbins E,
and
Häussinger D.
Functional significance of cell volume regulatory mechanisms.
Physiol Rev
79:
247-306,
1998.
31.
Law, RO,
and
Turner DPJ
Are ninhydrin-positive substances volume-regulatory osmolytes in rat renal papillary cells?
J Physiol (Lond)
386:
45-61,
1987
32.
Luh, EH,
Shackford SR,
Shatos MA,
and
Pietropaoli JA.
The effects of hyperosmolarity on the viability and function of endothelial cells.
J Surg Res
60:
122-128,
1996[ISI][Medline].
33.
Mosser, DD,
Theodorakis NG,
and
Morimoto RI.
Organization, nucleotide sequence and transcription of the chicken HSP70 gene.
J Biol Chem
261:
12692-12699,
1988
34.
O'Donnell, ME.
Role of Na-K-Cl cotransport in vascular endothelial cell volume regulation.
Am J Physiol Cell Physiol
264:
C1316-C1326,
1993
35.
O'Donnell, ME,
Martinez A,
and
Sun D.
Endothelial Na-K-Cl cotransport regulation by tonicity and hormones: phosporylation of cotransport protein.
Am J Physiol Cell Physiol
269:
C1513-C1523,
1995
36.
O'Neill, WC.
Physiological significance of volume-regulatory transporters.
Am J Physiol Cell Physiol
276:
C995-C1011,
1999
37.
O'Neill, WC,
and
Klein JD.
Regulation of vascular endothelial cell volume by Na-K-Cl cotransport.
Am J Physiol Cell Physiol
262:
C436-C444,
1992
38.
Pardee, AB.
Cell division and hypothesis of cancer.
Nat Cancer Inst Monogr
14:
7-14,
1964.
39.
Petronini, PG,
Alfieri R,
Campanini C,
and
Borghetti AF.
Effect of an alkaline shift on induction of the heat shock response in human fibroblasts.
J Cell Physiol
162:
322-329,
1995[ISI][Medline].
40.
Petronini, PG,
Alfieri RA,
De Angelis E,
Campanini C,
Borghetti AF,
and
Wheeler KP.
Different HSP70 expression and cell survival during adaptive responses of 3T3 and transformed 3T3 cells to osmotic stress.
Br J Cancer
67:
493-499,
1993[ISI][Medline].
41.
Petronini, PG,
De Angelis E,
Borghetti AF,
and
Wheeler KP.
Osmotically inducible uptake of betaine via amino acid transport system A in SV-3T3 cells.
Biochem J
300:
45-50,
1994.
42.
Petronini, PG,
Tramacere M,
Kay JE,
and
Borghetti AF.
Adaptive response of cultured fibroblasts to hyperosmolarity.
Exp Cell Res
165:
180-190,
1986[ISI][Medline].
43.
Petronini, PG,
Tramacere M,
Mazzini A,
Piedimonte G,
Silvotti L,
and
Borghetti AF.
Hyperosmolarity-induced stress proteins in chick embryo fibroblasts.
Exp Cell Res
172:
450-462,
1987[ISI][Medline].
44.
Piedimonte, G,
Borghetti AF,
and
Guidotti GG.
Effect of cell density on growth rate and amino acid transport in simian virus40-transformed 3T3 cells.
Cancer Res
42:
4690-4693,
1982
45.
Robinson, JH.
Density regulation of amino acid transport in cultured, androgen-responsive tumor cells.
J Cell Physiol
89:
101-110,
1976.
46.
Ruiz-Montasell, B,
Gomez-Angelats M,
Casado FL,
Felipe A,
McGivan JD,
and
Pastor-Anglada M.
Evidence for a regulatory protein involved in the increased activity of system A for neutral amino acid transport in osmotically stressed cells.
Proc Natl Acad Sci USA
91:
9569-9573,
1994
47.
Sheikh-Hamad, D,
Di Mari J,
Suki WN,
Safirstein R,
Watts BA, III,
and
Rouse D.
p38 Kinase activity is essential for osmotic induction of mRNAs for HSP70 and transporter for organic solute betaine in Madin-Darby canine kidney cells.
J Biol Chem
273:
1832-1837,
1998
48.
Takenaka, M,
Preston AS,
Kwon HM,
and
Handler JS.
The tonicity-sensitive element that mediates increased transcription of the betaine transporter gene in response to hypertonic stress.
J Biol Chem
269:
29379-29381,
1994
49.
Tramacere, M,
Petronini PG,
Severini A,
and
Borghetti AF.
Osmoregulation of amino acid transport activity in cultured fibroblasts.
Exp Cell Res
151:
70-79,
1984[ISI][Medline].
50.
Warskulat, U,
Wettstein M,
and
Häussinger D.
Betaine is an osmolyte in RAW 264.7 mouse macrophages.
FEBS Letters
377:
47-50,
1995[ISI][Medline].
51.
Weik, C,
Warskulat U,
Bode J,
Peters-Regehr T,
and
Haussinger D.
Compatible osmolytes in rat liver sinusoidal endothelial cells.
Hepatology
27:
569-575,
1998[ISI][Medline].
52.
Yamauchi, A,
Uchida S,
Kwon HM,
Preston AS,
Robey BR,
Garcia-Perez A,
Burg MB,
and
Handler JS.
Cloning of a Na+-dependent and Cl
-dependent betaine transporter that is regulated by hypertonicity.
J Biol Chem
267:
649-652,
1992
53.
Yancey, PH,
Clark ME,
Hand SC,
Bowlus RD,
and
Somero GN.
Living with water stress: evolution of osmolyte systems.
Science
217:
1214-1222,
1982
This article has been cited by other articles:
![]() |
R. R. Alfieri, M. A. Bonelli, A. Cavazzoni, M. Brigotti, C. Fumarola, P. Sestili, P. Mozzoni, G. De Palma, A. Mutti, D. Carnicelli, et al. Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress J. Physiol., October 15, 2006; 576(2): 391 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cai, J. D. Ferraris, and M. B. Burg High NaCl increases TonEBP/OREBP mRNA and protein by stabilizing its mRNA Am J Physiol Renal Physiol, October 1, 2005; 289(4): F803 - F807. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kempson, V. Parikh, L. Xi, S. Chu, and M. H. Montrose Subcellular redistribution of the renal betaine transporter during hypertonic stress Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1091 - C1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Mann, D. L. Yudilevich, and L. Sobrevia Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells Physiol Rev, January 1, 2003; 83(1): 183 - 252. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||